Tarsus Pharmaceuticals (TARS) Financials: Revenue & Earnings
TARS$71.80+1.04 +1.47%
$3.36B
Market Cap
-64.85
P/E
70.12
Forward P/E
65
Score
Tarsus Pharmaceuticals (TARS) Financials: Revenue & Earnings
TARS price $71.80 +1.04 +1.47%
- Ticker
- TARS
- Price
- $71.80
- Change
- +1.04 +1.47%
- Market cap ?
- $3.36B
- P/E ?
- -64.85
- Forward P/E ?
- 70.12
- Dividend yield ?
- 0.00%
- Beta ?
- 0.54
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
- Value
- 45
- Quality
- 54
- Growth
- 95
Stocklytics score rationale: value 45, quality 54, growth 95.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 57027000 | 25816000 | 17447000 | 182953000 | 451360000 |
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is…
Fair value
TARS fair value $79.42. Price $71.80. Price is 10% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 125.10M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 46.79M. Net debt -90.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -1.49 | — | 186.56M |
| 2026-08-06 | -0.43 | -0.19 | 173.91M | 169.65M |
| 2026-05-06 | -0.16 | -0.40 | 162.05M | 149.60M |
| 2026-02-23 | -0.20 | -0.10 | 151.67M | 144.57M |
| 2025-11-04 | -0.30 | -0.35 | 118.70M | 144.64M |
| 2025-08-06 | -0.48 | -0.33 | 102.66M | 113.05M |
| 2025-05-01 | -0.64 | -0.69 | 78.33M | 99.11M |
| 2025-02-25 | -0.60 | -0.68 | 66.41M | 64.45M |
| 2024-11-13 | -0.61 | -0.94 | 48.12M | 43.18M |
| 2024-08-08 | -0.88 | -0.98 | 40.81M | 31.66M |
| 2024-05-08 | -1.01 | -1.15 | 27.61M | 17.46M |
| 2024-02-27 | -1.31 | -1.37 | 13.08M | 5.66M |
| 2023-11-09 | -1.28 | -1.40 | 1.87M | 5.94M |
| 2023-08-10 | -1.17 | -1.08 | 15.28M | 1.76M |
| 2023-05-09 | -0.88 | -0.95 | 2.50M | 3.12M |
| 2023-03-13 | -0.49 | -0.97 | 10.00M | 10.00M |
| 2022-11-09 | -0.84 | -0.98 | — | 3.50M |
| 2022-08-11 | -0.24 | -0.65 | 15.28M | 11.25M |
| 2022-05-10 | -0.98 | -0.87 | 539.00K | 5.20M |
| 2022-03-14 | -0.72 | -0.77 | 338.00K | 1.87M |
| 2021-11-09 | -0.76 | -0.65 | 1.24M | 5.33M |
| 2021-08-04 | 0.33 | -0.48 | 22.02M | 22.02M |
| 2021-05-11 | 0.47 | -0.64 | 33.43M | 82.27M |
| 2021-03-31 | -0.68 | -0.66 | — | — |
| 2020-11-25 | -3.71 | -0.50 | — | — |
| 2020-10-16 | -0.30 | — | — | — |
| 2020-03-31 | -0.18 | — | — | — |
| 2019-12-31 | -0.13 | — | — | — |
| 2019-09-30 | -0.06 | — | — | — |
| 2018-06-30 | -0.08 | — | — | — |
| 2018-03-31 | -0.08 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | PYOTT DAVID E I | Buy | 201 | — | — |
| 2026-09-15 | PYOTT DAVID E I | Sell | 201 | — | — |
| 2026-09-15 | YARNO WENDY L | Buy | 302 | — | — |
| 2026-09-15 | YARNO WENDY L | Sell | 302 | — | — |
| 2026-09-15 | LINK WILLIAM J PHD | Buy | 201 | — | — |
| 2026-09-15 | LINK WILLIAM J PHD | Sell | 11.68K | $78.33 | 914.50K |
| 2026-09-15 | LINK WILLIAM J PHD | Sell | 759 | $79.00 | 59.96K |
| 2026-09-15 | LINK WILLIAM J PHD | Sell | 66 | $80.01 | 5.28K |
| 2026-09-15 | LINK WILLIAM J PHD | Sell | 201 | — | — |
| 2026-09-04 | Azamian Bobak R. | Sell | 7.10K | $90.27 | 640.92K |
| 2026-09-04 | Azamian Bobak R. | Sell | 2.90K | $91.27 | 264.68K |
| 2026-09-04 | Lin Elizabeth Yeu | Sell | 5.39K | $85.00 | 457.89K |
| 2026-09-04 | Lin Elizabeth Yeu | Sell | 1.59K | $85.00 | 135.15K |
| 2026-09-04 | Lin Elizabeth Yeu | Sell | 5.39K | $90.00 | 484.74K |
| 2026-09-04 | Lin Elizabeth Yeu | Sell | 1.59K | $90.00 | 143.10K |
| 2026-09-04 | Neervannan Seshadri | Sell | 4.56K | $85.00 | 387.94K |
| 2026-09-02 | Azamian Bobak R. | Sell | 10.00K | $80.06 | 800.60K |
| 2026-09-02 | Lin Elizabeth Yeu | Sell | 5.39K | $80.00 | 430.96K |
| 2026-09-02 | Lin Elizabeth Yeu | Sell | 1.59K | $80.00 | 127.20K |
| 2026-09-01 | Lin Elizabeth Yeu | Sell | 4.60K | $73.86 | 339.83K |
| 2026-06-25 | Goodrich Katherine | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | Goodrich Katherine | Buy | 2.42K | — | — |
| 2026-06-25 | Goldberg Andrew D. | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | Goldberg Andrew D. | Buy | 2.42K | — | — |
| 2026-06-25 | Morrison Scott W | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | Morrison Scott W | Buy | 2.42K | — | — |
| 2026-06-25 | CHAUDHURI BHASKAR | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | CHAUDHURI BHASKAR | Buy | 2.42K | — | — |
| 2026-06-25 | YARNO WENDY L | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | YARNO WENDY L | Buy | 2.42K | — | — |
| 2026-06-25 | YARNO WENDY L | Buy | 1.21K | — | — |
| 2026-06-25 | PYOTT DAVID E I | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | PYOTT DAVID E I | Buy | 2.42K | — | — |
| 2026-06-25 | PYOTT DAVID E I | Buy | 806 | — | — |
| 2026-06-25 | LINK WILLIAM J PHD | Buy | 3.84K | $64.34 | 246.87K |
| 2026-06-25 | LINK WILLIAM J PHD | Buy | 2.42K | — | — |
| 2026-06-25 | LINK WILLIAM J PHD | Buy | 806 | — | — |
| 2026-06-17 | Azamian Bobak R. | Sell | 4.58K | $61.24 | 280.60K |
| 2026-06-17 | Azamian Bobak R. | Sell | 5.42K | $61.81 | 334.89K |
| 2026-06-16 | Farrow Jeffrey S | Sell | 14.40K | $60.95 | 877.44K |
| 2026-06-15 | Farrow Jeffrey S | Buy | 27.88K | — | — |
| 2026-06-15 | Farrow Jeffrey S | Sell | 27.88K | — | — |
| 2026-06-15 | Goodrich Katherine | Sell | 2.95K | $62.08 | 183.38K |
| 2026-06-15 | LINK WILLIAM J PHD | Sell | 10.57K | $61.97 | 655.15K |
| 2026-06-15 | LINK WILLIAM J PHD | Sell | 1.93K | $62.94 | 121.35K |
| 2026-06-12 | Morrison Scott W | Buy | 2.95K | — | — |
| 2026-06-12 | Morrison Scott W | Sell | 2.95K | — | — |
| 2026-06-12 | LINK WILLIAM J PHD | Buy | 2.95K | — | — |
| 2026-06-12 | LINK WILLIAM J PHD | Sell | 2.95K | — | — |
| 2026-06-12 | CHAUDHURI BHASKAR | Buy | 2.95K | — | — |
| 2026-06-12 | CHAUDHURI BHASKAR | Sell | 2.95K | — | — |
| 2026-06-12 | Goodrich Katherine | Buy | 2.95K | — | — |
| 2026-06-12 | Goodrich Katherine | Sell | 2.95K | — | — |
| 2026-06-12 | YARNO WENDY L | Buy | 2.95K | — | — |
| 2026-06-12 | YARNO WENDY L | Sell | 2.95K | — | — |
| 2026-06-12 | Goldberg Andrew D. | Buy | 2.95K | — | — |
| 2026-06-12 | Goldberg Andrew D. | Sell | 2.95K | — | — |
| 2026-04-24 | PYOTT DAVID E I | Buy | 1.38K | — | — |
| 2026-04-24 | PYOTT DAVID E I | Sell | 1.38K | — | — |
| 2026-03-20 | Neervannan Seshadri | Sell | 2.99K | $66.75 | 199.52K |
| 2026-03-19 | Whitfield Dianne C. | Sell | 4.17K | $67.00 | 279.66K |
| 2026-03-19 | Wahl Bryan | Sell | 4.23K | $67.00 | 283.48K |
| 2026-03-19 | Neervannan Seshadri | Sell | 4.59K | $67.00 | 307.46K |
| 2026-03-19 | Mottiwala Aziz | Sell | 4.44K | $67.00 | 297.48K |
| 2026-03-19 | Lin Elizabeth Yeu | Sell | 390 | $67.00 | 26.13K |
| 2026-03-19 | Farrow Jeffrey S | Sell | 2.19K | $67.00 | 146.46K |
| 2026-03-19 | Azamian Bobak R. | Sell | 11.96K | $67.00 | 801.59K |
| 2026-03-18 | Whitfield Dianne C. | Sell | 4.07K | $68.71 | 279.72K |
| 2026-03-18 | Wahl Bryan | Sell | 4.12K | $68.71 | 283.43K |
| 2026-03-18 | Neervannan Seshadri | Sell | 3.61K | $68.71 | 248.04K |
| 2026-03-18 | Mottiwala Aziz | Sell | 4.33K | $68.71 | 297.51K |
| 2026-03-18 | Lin Elizabeth Yeu | Sell | 379 | $68.71 | 26.04K |
| 2026-03-18 | Farrow Jeffrey S | Sell | 2.13K | $68.71 | 146.56K |
| 2026-03-18 | Azamian Bobak R. | Sell | 11.67K | $68.71 | 801.64K |
| 2026-03-17 | Whitfield Dianne C. | Sell | 4.03K | $69.42 | 279.69K |
| 2026-03-17 | Wahl Bryan | Sell | 4.08K | $69.42 | 283.51K |
| 2026-03-17 | Neervannan Seshadri | Sell | 3.12K | $69.42 | 216.94K |
| 2026-03-17 | Mottiwala Aziz | Sell | 4.29K | $69.42 | 297.53K |
| 2026-03-17 | Lin Elizabeth Yeu | Sell | 375 | $69.42 | 26.03K |
| 2026-03-17 | Farrow Jeffrey S | Sell | 2.11K | $69.42 | 146.55K |
| 2026-03-17 | Azamian Bobak R. | Sell | 10.97K | $69.42 | 761.68K |
| 2026-03-16 | LINK WILLIAM J PHD | Sell | 3.63K | $68.09 | 247.10K |
| 2026-03-16 | LINK WILLIAM J PHD | Sell | 8.38K | $69.03 | 578.33K |
| 2026-03-16 | LINK WILLIAM J PHD | Sell | 493 | $69.75 | 34.39K |
| 2026-03-15 | Whitfield Dianne C. | Buy | 23.91K | — | — |
| 2026-03-15 | Whitfield Dianne C. | Sell | 5.02K | — | — |
| 2026-03-15 | Whitfield Dianne C. | Sell | 7.18K | — | — |
| 2026-03-15 | Whitfield Dianne C. | Sell | 7.25K | — | — |
| 2026-03-15 | Whitfield Dianne C. | Sell | 4.46K | — | — |
| 2026-03-15 | Wahl Bryan | Buy | 24.24K | — | — |
| 2026-03-15 | Wahl Bryan | Sell | 5.02K | — | — |
| 2026-03-15 | Wahl Bryan | Sell | 7.18K | — | — |
| 2026-03-15 | Wahl Bryan | Sell | 7.25K | — | — |
| 2026-03-15 | Wahl Bryan | Sell | 4.79K | — | — |
| 2026-03-15 | Neervannan Seshadri | Buy | 26.29K | — | — |
| 2026-03-15 | Neervannan Seshadri | Sell | 8.02K | — | — |
| 2026-03-15 | Neervannan Seshadri | Sell | 5.02K | — | — |
| 2026-03-15 | Neervannan Seshadri | Sell | 8.15K | — | — |
| 2026-03-15 | Neervannan Seshadri | Sell | 5.10K | — | — |
| 2026-03-15 | Mottiwala Aziz | Buy | 26.48K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 270, holders +10 vs prior quarter. Ownership 109.83%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 3.86M | 303.52K | +8.54% | 242.71M |
| DEEP TRACK CAPITAL, LP | 3.67M | 66.77K | +1.85% | 230.79M |
| RTW INVESTMENTS, LP | 3.36M | 11.03K | +0.33% | 211.29M |
| JUPITER TOPCO LLC | 2.81M | 2.81M | New | 176.83M |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.78M | 213.50K | +8.33% | 174.70M |
| MORGAN STANLEY | 1.83M | -117.19K | -6.03% | 115.00M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.79M | 32.52K | +1.85% | 112.86M |
| JENNISON ASSOCIATES LLC | 1.66M | -48.47K | -2.83% | 104.71M |
| TANG CAPITAL MANAGEMENT LLC | 1.57M | 379.64K | +31.94% | 98.71M |
| MILLENNIUM MANAGEMENT LLC | 1.43M | 862.54K | +152.78% | 89.82M |
| BANK OF AMERICA CORP /DE/ | 1.19M | -1.20K | -0.10% | 75.10M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.11M | -15.40K | -1.37% | 69.61M |
| STATE STREET CORP | 1.07M | 94.74K | +9.68% | 67.53M |
| VESTAL POINT CAPITAL, LP | 1.05M | 850.00K | +425.00% | 66.09M |
| ASSENAGON ASSET MANAGEMENT S.A. | 947.50K | -332.70K | -25.99% | 59.64M |
| INVESCO LTD. | 785.81K | 43.31K | +5.83% | 49.46M |
| GOLDMAN SACHS GROUP INC | 742.69K | 303.07K | +68.94% | 46.75M |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 728.64K | 0 | 0.00% | 45.86M |
| D. E. SHAW & CO., INC. | 710.56K | -80.59K | -10.19% | 44.72M |
| FMR LLC | 672.95K | -60.38K | -8.23% | 42.36M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 607.27K | 107.42K | +21.49% | 38.22M |
| CLEARBRIDGE INVESTMENTS, LLC | 549.39K | 4.04K | +0.74% | 34.58M |
| TORONTO DOMINION BANK | 510.25K | 0 | 0.00% | 32.12M |
| LORD, ABBETT & CO. LLC | 479.27K | -363.05K | -43.10% | 30.16M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 427.01K | 427.01K | New | 26.88M |
Earnings and financials
Tarsus Pharmaceuticals, Inc. (TARS) trades at $71.80, with a market cap of $3.36B and a trailing P/E of -64.85. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 57027000 | 25816000 | 17447000 | 182953000 | 451360000 |
Insights · Dividends · Forecast · Financials · Learn